SEC Form 4 · accession 0001384101-17-000020
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Brooks
Officer — EVP, Gen Counsel and Secretary
Period of report
Mar 3, 2017
Accepted (ET)
Mar 6, 2017 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2017 | A | 377 | $4.23 | A | 4,162 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $9.05 | Mar 3, 2017 | A | 60,000 | A | — | Mar 3, 2027 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
- F2The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.